Hepatitis & liver cancer risk explored in immigrant communities
NCT ID NCT02366286
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested 892 African and Asian immigrants for hepatitis B and C to understand how these infections raise the risk of liver cancer. Researchers also checked vaccination rates and tracked new cancer cases over time. No treatment was given; the goal was to gather information to improve screening and prevention in these communities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Finger-Prick could change the fight against hepatitis c
- A simple finger prick could transform hepatitis c care
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can a simple belly press make liver cancer radiation more precise?
- Can hepatitis c be cured in just 4 weeks? a new trial puts it to the test
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure